2 shares for value investors to consider buying

Investors looking for value shares might want to consider 3i and Pfizer as stocks that aren’t getting the attention they currently deserve.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Value investing’s about buying shares for less than their intrinsic value. But estimating what a company’s worth can be challenging, even for the likes of billionaire investor Warren Buffett.

Stocks don’t come with labels that say when they’re undervalued, but there are some things investors can look for. And I think there are a couple of interesting candidates right now.

3i 

3i Group‘s (LSE:III) been one of this year’s better-performing UK shares. But I think the stock’s still worth considering for value investors looking for opportunities. 

Should you invest £1,000 in Advanced Micro Devices right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Advanced Micro Devices made the list?

See the 6 stocks

Created with Highcharts 11.4.33i Group Plc PriceZoom1M3M6MYTD1Y5Y10YALL4 Sep 20194 Sep 2024Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '242020202020212021202220222023202320242024www.fool.co.uk

At a price-to-earnings (P/E) ratio of just under 8, investors might not expect much in the way of growth. But there’s a lot going on beneath the surface that’s worth paying attention to.

The firm’s largest investment is in Action – a discount retailer based in the Netherlands, which 3i values at around £12bn. This makes up around 66% of the investment portfolio.

Investors should note the company’s valuation of its asset might be on the aggressive side. The likes of peers B&M European Value and Five Below both trade at lower multiples of sales.

Action however, has been growing impressively. Sales are up 22% over the last 12 months and margins have been expanding, boosting profitability. 

I think that makes the value equation on 3i shares quite interesting, especially with the stock trading at a low P/E multiple. 

Pfizer

The end of the pandemic heralded a downturn for the Pfizer (NYSE:PFE) share price. Falling demand for Covid-19 vaccines – predictably – caused sales and profits to fall.

Created with Highcharts 11.4.3Pfizer PriceZoom1M3M6MYTD1Y5Y10YALL4 Sep 20194 Sep 2024Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '242020202020212021202220222023202320242024www.fool.co.uk

On top of that, the company’s fallen behind the likes of Eli Lilly and Novo Nordisk in the race to develop anti-obesity drugs. But I think the stock looks interesting at the moment. 

The challenge with pharmaceutical stocks – especially big ones – is growth. With just under $60bn in annual sales, generating meaningful revenue growth isn’t easy.

Furthermore, assessing the strength of Pfizer’s pipeline is far from straightforward. Doing this accurately involves a lot of technical knowledge that most investors are unlikely to have. 

That’s why it’s important to insist on a margin of safety with this type of business. And I think this is available right now for investors considering buying the stock.

Analysts have an average price target of $34.10 – almost 18% above than the current level. And while value stocks aren’t known for being innovative, Pfizer’s a lot going for it.

Investors need a short memory to forget how quickly the company developed a Covid-19 vaccine in an emergency. So I wouldn’t count them out of the GLP-1 industry just yet.

Value investing

Value investing isn’t just about buying shares that trade at low multiples. A lot of the time, stocks trade at discount prices because the underlying businesses have permanent problems. 

When looking for a margin of safety though, this can be a good place to start looking. And I think both 3i and Pfizer are interesting opportunities for value investors to consider.

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stephen Wright has positions in Five Below and Pfizer. The Motley Fool UK has recommended B&M European Value and Novo Nordisk. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£20K invested in Tesla stock last April is now worth…

Despite all the bad headlines lately, Tesla stock has put in a storming performance over a 12-month timeframe. Is this…

Read more »

Investing Articles

If a 40 year old invests £600 a month in a SIPP, here’s what they could have by retirement

With no retirement savings at 40, an investor could put £600 a month into a SIPP and grow its value…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Why hasn’t its 9.9% yield boosted the Phoenix share price?

Phoenix Group has a dividend close to double digits, but saw a weak share price performance in recent years. Christopher…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

With average 10% yields, these mid-cap FTSE shares could supercharge a passive income portfolio

Some of the best passive income gems can be found on the UK's smaller indexes like the FTSE 250 and…

Read more »

A coin being dropped into a piggy bank
Investing Articles

As the Barclays share price tanks 19% in 2 days, is this a great buying opportunity?

As a trade war sends the Barclays share price into a tailspin, Andrew Mackie steps back to look at the…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is Fundsmith Equity still a good choice for a Stocks and Shares ISA in 2025?

Many Britons hold the Fundsmith Equity fund in their Stocks and Shares ISAs. Is this still a good move? Edward…

Read more »

Investing Articles

Nvidia stock is down 24% this year. Time to buy the dip?

Christopher Ruane has been eyeing Nvidia stock as a potential addition to his portfolio for a while. Is a recent…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Down 25% since January, this resilient dividend stock’s catching my eye

Maintaining the UK’s rail, water, and energy infrastructure isn’t the most exciting business. But it has made this a solid…

Read more »